Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KLK5 | Q9Y337 | 3/20 | 0.51 |
| ▸ | PSEN1 | P49768 | 3/20 | 0.45 |
| ▸ | PSEN2 | P49810 | 3/20 | 0.45 |
| ▸ | APH1B | Q8WW43 | 3/20 | 0.45 |
| ▸ | NCSTN | Q92542 | 3/20 | 0.45 |
| ▸ | APH1A | Q96BI3 | 3/20 | 0.45 |
| ▸ | PSENEN | Q9NZ42 | 3/20 | 0.45 |
| ▸ | APP | P05067 | 1/20 | 0.45 |
| ▸ | ATM | Q13315 | 1/20 | 0.42 |
| ▸ | CTSS | P25774 | 6/20 | 0.41 |
| ▸ | CTSK | P43235 | 5/20 | 0.41 |
| ▸ | CTSL | P07711 | 1/20 | 0.40 |
| ▸ | CTSB | P07858 | 1/20 | 0.40 |
| ▸ | CA1 | P00915 | 1/20 | 0.40 |
| ▸ | CA2 | P00918 | 1/20 | 0.40 |
| ▸ | CA7 | P43166 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20469109 | 1.00 | KLK5 (0.51) | KLK5PSEN1PSEN2APH1BNCSTN | |
| SCHEMBL24924906 | 0.88 | KLK5 (0.49) | KLK5PSEN1PSEN2APH1BNCSTN | |
| SCHEMBL28034674 | 0.88 | CTSS (0.54) | KLK5PSEN1PSEN2APH1BNCSTN | |
| SCHEMBL15005230 | 0.87 | KLK5 (0.65) | KLK5PSEN1PSEN2APH1BNCSTN | |
| SCHEMBL3031552 | 0.87 | KLK5 (0.65) | KLK5PSEN1PSEN2APH1BNCSTN | |
| SCHEMBL15005231 | 0.87 | KLK5 (0.65) | KLK5PSEN1PSEN2APH1BNCSTN | |
| SCHEMBL1601995 | 0.87 | KLK5 (0.65) | KLK5PSEN1PSEN2APH1BNCSTN | |
| SCHEMBL1602032 | 0.87 | KLK5 (0.65) | KLK5PSEN1PSEN2APH1BNCSTN | |
| SCHEMBL8224118 | 0.86 | KLK5 (0.53) | KLK5PSEN1PSEN2APH1BNCSTN | |
| SCHEMBL20456774 | 0.84 | KLK5 (0.48) | KLK5PSEN1PSEN2APH1BNCSTN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3909949-A1 | ATAZANAVIR (ATV) ANALOGUES FOR TREATING HIV INFECTIONS | Gilead Sciences, Inc. (US) | 2021-11-17 | — | — | EP | disclosed |
| EP-3577110-B1 | 8-OXETAN-3-YL-3,8-DIAZABICYCLO[3.2.1]OCTAN-3-YL SUBSTITUTED COMPOUNDS AS HIV INHIBITORS | GILEAD SCIENCES INC (US) | 2021-04-21 | — | — | EP | disclosed |
| WO-2018145021-A1 | ATAZANAVIR (ATV) ANALOGUES FOR TREATING HIV INFECTIONS | GILEAD SCIENCES, INC. (US) | 2018-08-09 | — | — | WO | disclosed |